Android app Apple app link

Madrigal Pharmaceuticals, Inc. (MDGL) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$339.92

north_east
$15.21 (4.68%)
Day's range
$313.72
Day's range
$346.04

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
05/29/2024 Piper Sandler Yasmeen Rahimi $336.00 $221.76   51.52%
05/09/2024 H.C. Wainwright Ed Acre $390.00 $208.04   87.46%
03/19/2024 Evercore ISI Liisa Bayko $405.00 $265.68   52.44%
03/15/2024 UBS Eliana Merle $410.00 $270.37   51.64%
03/15/2024 Jefferies Akash Tewari $400.00 $270.37   47.95%
03/15/2024 H.C. Wainwright Ed Acre $425.00 $270.37   57.19%
03/14/2024 JMP Securities Jonathan Wolleben $397.00 $270.37   46.84%
03/14/2024 B.Riley Financial Mayank Mamtani $270.00 $270.37   -0.14%
08/05/2021 BMO Capital Matthew Luchini $111.00 $90.95   22.05%
05/19/2021 Goldman Sachs Andrea Tan $195.00 $129.77   50.27%
05/05/2021 Wells Fargo Derek Archila $130.00 $126.71   2.6%

Madrigal Pharmaceuticals, Inc. FAQ's

What analysts cover Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. has been rated by research analysts at Piper Sandler, H.C. Wainwright, Evercore ISI, UBS, Jefferies, JMP Securities in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.